KINTSUGI 440

Kintsugi 440mg Injection contains the active ingredient Trastuzumab, a monoclonal antibody used in the treatment of HER2-positive breast cancer and metastatic gastric cancer with overexpression of the HER2 protein. HER2-positive cancers tend to be more aggressive, and Trastuzumab works as a targeted therapy by selectively binding to the HER2 receptors, thereby blocking the signals that promote cancer cell growth and survival.

This medication is not recommended for patients under 18 years of age, or those with severe respiratory issues requiring oxygen therapy. Inform your physician if you have a history of heart disease, breathlessness, or have previously received cancer treatments, as these conditions may influence the safety and effectiveness of Trastuzumab.

It is essential to use effective birth control during treatment and for at least 7 months after the final dose, as this medication can harm an unborn baby. Prior to starting treatment, inform your doctor of all medications you are taking, including prescription and over-the-counter drugs, supplements, and herbal products, to avoid potential interactions